Services
Home  Services
Different services offered by Flagship Biotech International
Pharma Product supply :
Finished formulations / medicines.
Oral solid dosages (Tablets, Capsules, Soft Gels)
Oral liquid dosages (Syrups, Dry Syrups, Suspensions)
Small & Large Volume Parenterals
Sterile Injectibles & Dry Powder Injections
Eye, Ear, Nasal Preparations
Ointments, Creams, Lotions, Gels, Other Topicals
Suppositories, Pessaries & Patches
Bulk actives (API) - technical grade, DMF grade (USDMF, EDMF, JDMF), COS & CEP grade.
Raw materials & intermediates
Products can be supplied for all markets of USA, Europe, Latin America, Africa, CIS, Middle East & Rest of Asia spanning the entire range of therapeutic categories viz :
Cardiovascular
Neurology & Neuro-Psychiatry
Anti-infectives (Fungal, Bacterial, Viral, Protozoal, Parasites)
Gastrointestinal (PPI's, Antacids)
Biotech Products (Recombinant Therapeutic Proteins)
Hormone & Steroid Preparations
Urology & Nephrology
Entire Range of Herbals
Oncology
Haemotology & Enzyme Preparations
OTC Products - Pain, Vitamins & Minerals, Nutraceuticals, etc.
Others
All manufacturing sites have various GMP approvals, viz WHO GMP, UK MHRA, Brazil ANVISA Australian TGA, USFDA, Health Canada, South African MCC, New Zealand Medsafe & other approvals like GCC, Iran MOH, Ethiopian DACA, NAFDAC, Tanzanian MOH, Ugandan NDA, Mexican MOH, Columbian INVIMA, Ukraine MOH. Full registration dossier support upto the EU – CTD level can be provided for all product categories as appropriate.
Global pharma Project consultation for :
Site Variation
API Variation
In-Licensing
Out-Licensing
Technology Transfer platforms esp for development of Recombinant Therapeutic protein Biosimilars.
Turnkey project consultation for API & finished formulation facility set up from concept stage.
US generic ANDA projects.
Business Development
Expansion of pharma export business for global clients for business entry or growth into all markets of Europe, Latin America, Africa, CIS, Middle East & Rest of Asia.
Flagship will identify the best business model for pharma business initiation or growth in a particular territory including local partner identification, market & opportunity assessment, registration support, commercialization dynamics & business strategization.
|
|
|
